Stay updated on Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    No additions or deletions were listed for this page, so the content remains as published. The provided data shows no textual changes to assess in context.
    Difference
    0.0%
    Check dated 2026-08-23T18:53:18.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing Revision: v3.6.4, indicating a minor version update to the page. This reflects internal maintenance rather than substantive changes to the study information.
    Difference
    0.0%
    Check dated 2026-08-09T09:17:07.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4 on the page, reflecting a minor internal update to the page's software/versioning rather than changes to study content.
    Difference
    0.0%
    Check dated 2026-07-25T18:05:28.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.6.2 to v3.6.3. This reflects a new release of the page’s software/content management update.
    Difference
    0.0%
    Check dated 2026-07-04T13:35:26.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Footer revision label updated to v3.6.2, replacing v3.6.0, indicating a site revision rather than changes to the study content.
    Difference
    0.0%
    Check dated 2026-06-27T08:01:03.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2026-06-13T05:18:19.000Z thumbnail image

Stay in the know with updates to Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page.